Dolores J Schendel

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 2

Top Topics

Ejection Fraction

Randomized Controlled Trial

Acute Lymphoblastic Leukemia

End Stage Renal Disease

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Yngvar Fløisand, Mats Remberger, Iris Bigalke, Dag Josefsen, Helen Vålerhaugen, Else Marit Inderberg, Richard W Olaussen, Bjorn Tore Gjertsen, Rene Goedkoop, Christiane Geiger, Petra U Prinz, Frauke M Schnorfeil, Kai Pinkernell, Dolores J Schendel, Gunnar Kvalheim
WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy. Leukemia (2023)
Anne M A Tryggestad, Karol Axcrona, Ulrika Axcrona, Iris Bigalke, Bjørn Brennhovd, Else Marit Inderberg, Turid K Hønnåshagen, Lisbeth J Skoge, Guri Solum, Stein Saebøe-Larssen, Dag Josefsen, Richard W Olaussen, Steinar Aamdal, Rolf I Skotheim, Tor-Åge Myklebust, Dolores J Schendel, Wolfgang A Lilleby, Svein Dueland, Gunnar Kvalheim
Long-term first-in-man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomy. The Prostate (2021)